Allergic diseases are particularly suitable for personalized medicine, because they meet the needs for therapeutic success, which include a known molecular mechanism of the disease, a diagnostic tool for that disease and a treatment that blocks this mechanism. A range of tools is available for personalized allergy diagnosis, including molecular diagnostics, treatable traits and omics (i.e., proteomics, epigenomics, metabolomics, transcriptomics and breathomics), to predict patient response to therapies, detect biomarkers and mediators and assess disease control status. Such tools enhance allergen immunotherapy. Higher diagnostic accuracy results in a significant increase (based on a greater performance achieved with personalized treatment) in efficacy, further increasing the known and unique characteristics of a treatment designed to work on allergy causes.

The present and future of allergen immunotherapy in personalized medicine / Ridolo, E.; Incorvaia, C.; Heffler, E.; Cavaliere, C.; Paoletti, G.; Canonica, G. W.. - In: JOURNAL OF PERSONALIZED MEDICINE. - ISSN 2075-4426. - 12:5(2022). [10.3390/jpm12050774]

The present and future of allergen immunotherapy in personalized medicine

Cavaliere C.
Supervision
;
2022

Abstract

Allergic diseases are particularly suitable for personalized medicine, because they meet the needs for therapeutic success, which include a known molecular mechanism of the disease, a diagnostic tool for that disease and a treatment that blocks this mechanism. A range of tools is available for personalized allergy diagnosis, including molecular diagnostics, treatable traits and omics (i.e., proteomics, epigenomics, metabolomics, transcriptomics and breathomics), to predict patient response to therapies, detect biomarkers and mediators and assess disease control status. Such tools enhance allergen immunotherapy. Higher diagnostic accuracy results in a significant increase (based on a greater performance achieved with personalized treatment) in efficacy, further increasing the known and unique characteristics of a treatment designed to work on allergy causes.
2022
allergen immunotherapy; omics; personalized medicine
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
The present and future of allergen immunotherapy in personalized medicine / Ridolo, E.; Incorvaia, C.; Heffler, E.; Cavaliere, C.; Paoletti, G.; Canonica, G. W.. - In: JOURNAL OF PERSONALIZED MEDICINE. - ISSN 2075-4426. - 12:5(2022). [10.3390/jpm12050774]
File allegati a questo prodotto
File Dimensione Formato  
Ridolo_The present and_2022.pdf

accesso aperto

Note: https://www.mdpi.com/2075-4426/12/5/774
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 612.85 kB
Formato Adobe PDF
612.85 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1640376
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
social impact